U.S. flag

An official website of the United States government

nsv917875

  • Variant Calls:6
  • Validation:Not tested
  • Clinical Assertions: Yes
  • Region Size:93,468

Links to Other Resources

Genome View

Select assembly:
Overlapping variant regions from other studies: 424 SVs from 36 studies. See in: genome view    
Remapped(Score: Perfect):8,633,452-8,726,919Question Mark
Overlapping variant regions from other studies: 424 SVs from 36 studies. See in: genome view    
Remapped(Score: Perfect):8,601,493-8,694,960Question Mark
Overlapping variant regions from other studies: 142 SVs from 9 studies. See in: genome view    
Submitted genomic8,561,493-8,654,960Question Mark

Variant Region Placement Information

Variant Region IDPlacement TypeScoreAssemblyAssembly UnitReciprocitySequence IDChrInner StartInner Stop
nsv917875RemappedPerfectGRCh38.p12Primary AssemblyFirst PassNC_000023.11ChrX8,633,4528,726,919
nsv917875RemappedPerfectGRCh37.p13Primary AssemblyFirst PassNC_000023.10ChrX8,601,4938,694,960
nsv917875Submitted genomicNCBI36 (hg18)Primary AssemblyNC_000023.9ChrX8,561,4938,654,960

Variant Call Information

Variant Call IDTypeSample IDMethodAnalysisSubject PhenotypeClinical InterpretationSource of InterpretationCopy number
nssv1605974copy number gainISCA_ID_pn_1660Oligo aCGHProbe signal intensityDevelopmental delay AND/OR other significant developmental or morphological phenotypesBenignSubmitter3
nssv1606498copy number gainISCA_ID_pn_2120Oligo aCGHProbe signal intensityDevelopmental delay AND/OR other significant developmental or morphological phenotypesBenignSubmitter2
nssv1606748copy number gainISCA_ID_pn_2343Oligo aCGHProbe signal intensityDevelopmental delay AND/OR other significant developmental or morphological phenotypesBenignSubmitter2
nssv1606865copy number gainISCA_ID_pn_297Oligo aCGHProbe signal intensityBilateral talipes equinovarusBenignSubmitter2
nssv1607393copy number gainISCA_ID_pn_769Oligo aCGHProbe signal intensityIncreased nuchal translucencyBenignSubmitter3
nssv1607426copy number gainISCA_ID_pn_798Oligo aCGHProbe signal intensityDevelopmental delay AND/OR other significant developmental or morphological phenotypesBenignSubmitter3

Variant Call Placement Information

Variant Call IDPlacement TypeScoreHGVSAssemblyReciprocitySequence IDChrInner StartInner Stop
nssv1605974RemappedPerfectNC_000023.11:g.(?_
8633452)_(8726919_
?)dup
GRCh38.p12First PassNC_000023.11ChrX8,633,4528,726,919
nssv1606498RemappedPerfectNC_000023.11:g.(?_
8633452)_(8726919_
?)dup
GRCh38.p12First PassNC_000023.11ChrX8,633,4528,726,919
nssv1606748RemappedPerfectNC_000023.11:g.(?_
8633452)_(8726919_
?)dup
GRCh38.p12First PassNC_000023.11ChrX8,633,4528,726,919
nssv1606865RemappedPerfectNC_000023.11:g.(?_
8633452)_(8726919_
?)dup
GRCh38.p12First PassNC_000023.11ChrX8,633,4528,726,919
nssv1607393RemappedPerfectNC_000023.11:g.(?_
8633452)_(8726919_
?)dup
GRCh38.p12First PassNC_000023.11ChrX8,633,4528,726,919
nssv1607426RemappedPerfectNC_000023.11:g.(?_
8633452)_(8726919_
?)dup
GRCh38.p12First PassNC_000023.11ChrX8,633,4528,726,919
nssv1605974RemappedPerfectNC_000023.10:g.(?_
8601493)_(8694960_
?)dup
GRCh37.p13First PassNC_000023.10ChrX8,601,4938,694,960
nssv1606498RemappedPerfectNC_000023.10:g.(?_
8601493)_(8694960_
?)dup
GRCh37.p13First PassNC_000023.10ChrX8,601,4938,694,960
nssv1606748RemappedPerfectNC_000023.10:g.(?_
8601493)_(8694960_
?)dup
GRCh37.p13First PassNC_000023.10ChrX8,601,4938,694,960
nssv1606865RemappedPerfectNC_000023.10:g.(?_
8601493)_(8694960_
?)dup
GRCh37.p13First PassNC_000023.10ChrX8,601,4938,694,960
nssv1607393RemappedPerfectNC_000023.10:g.(?_
8601493)_(8694960_
?)dup
GRCh37.p13First PassNC_000023.10ChrX8,601,4938,694,960
nssv1607426RemappedPerfectNC_000023.10:g.(?_
8601493)_(8694960_
?)dup
GRCh37.p13First PassNC_000023.10ChrX8,601,4938,694,960
nssv1605974Submitted genomicNC_000023.9:g.(?_8
561493)_(8654960_?
)dup
NCBI36 (hg18)NC_000023.9ChrX8,561,4938,654,960
nssv1606498Submitted genomicNC_000023.9:g.(?_8
561493)_(8654960_?
)dup
NCBI36 (hg18)NC_000023.9ChrX8,561,4938,654,960
nssv1606748Submitted genomicNC_000023.9:g.(?_8
561493)_(8654960_?
)dup
NCBI36 (hg18)NC_000023.9ChrX8,561,4938,654,960
nssv1606865Submitted genomicNC_000023.9:g.(?_8
561493)_(8654960_?
)dup
NCBI36 (hg18)NC_000023.9ChrX8,561,4938,654,960
nssv1607393Submitted genomicNC_000023.9:g.(?_8
561493)_(8654960_?
)dup
NCBI36 (hg18)NC_000023.9ChrX8,561,4938,654,960
nssv1607426Submitted genomicNC_000023.9:g.(?_8
561493)_(8654960_?
)dup
NCBI36 (hg18)NC_000023.9ChrX8,561,4938,654,960

No validation data were submitted for this variant

Clinical Assertions

Variant Call IDSample IDHGVSTypeSubject PhenotypeClinical InterpretationSource of InterpretationGenderAgeCopy number
nssv1605974ISCA_ID_pn_1660NCBI36: NC_000023.9:g.(?_8561493)_(8654960_?)dupcopy number gainDevelopmental delay AND/OR other significant developmental or morphological phenotypesBenignSubmitterFemale17 weeks gestation3
nssv1606498ISCA_ID_pn_2120NCBI36: NC_000023.9:g.(?_8561493)_(8654960_?)dupcopy number gainDevelopmental delay AND/OR other significant developmental or morphological phenotypesBenignSubmitterMale16 weeks gestation2
nssv1606748ISCA_ID_pn_2343NCBI36: NC_000023.9:g.(?_8561493)_(8654960_?)dupcopy number gainDevelopmental delay AND/OR other significant developmental or morphological phenotypesBenignSubmitterMale17 weeks gestation2
nssv1606865ISCA_ID_pn_297NCBI36: NC_000023.9:g.(?_8561493)_(8654960_?)dupcopy number gainBilateral talipes equinovarusBenignSubmitterMale12 weeks gestation2
nssv1607393ISCA_ID_pn_769NCBI36: NC_000023.9:g.(?_8561493)_(8654960_?)dupcopy number gainIncreased nuchal translucencyBenignSubmitterFemale11 weeks gestation3
nssv1607426ISCA_ID_pn_798NCBI36: NC_000023.9:g.(?_8561493)_(8654960_?)dupcopy number gainDevelopmental delay AND/OR other significant developmental or morphological phenotypesBenignSubmitterFemale11 weeks gestation3

No genotype data were submitted for this variant

Support Center